Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insights into N6-methyladenosine and programmed cell death in cancer
Li Liu, Hui Li, Dingyu Hu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 176

Showing 1-25 of 176 citing articles:

RNA modifications: importance in immune cell biology and related diseases
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 197
Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer
Lianhui Sun, Yuan Zhang, Boyu Yang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 153
The double-edged functions of necroptosis
Keng Ye, Zhimin Chen, Yanfang Xu
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 89
Epigenetic modification of m6A regulator proteins in cancer
Yumin Wang, Yan Wang, Harsh Patel, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 83
YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD‐L1/VEGFA Axis
Jingyuan Wen, Xue Lin, Wei Yi, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 26
Critical roles and clinical perspectives of RNA methylation in cancer
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 17
Employing Piezoelectric Mg2+‐Doped Hydroxyapatite to Target Death Receptor‐Mediated Necroptosis: A Strategy for Amplifying Immune Activation
Jiani Yang, Yaqian Du, Yuanfei Yao, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 16
Preclinical advance in nanoliposome-mediated photothermal therapy in liver cancer
Le Tang, Xiao Yang, Liwen He, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma
Jingsheng Yuan, Tao Lv, Jian Yang, et al.
Redox Biology (2022) Vol. 58, pp. 102546-102546
Open Access | Times Cited: 64
Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application
Fusheng Zhang, Haiyang Liu, Meiqi Duan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 59
Neutrophil extracellular traps-triggered impaired autophagic flux via METTL3 underlies sepsis-associated acute lung injury
Mengdi Qu, Zhaoyuan Chen, Zhiyun Qiu, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 59
Biological and pharmacological roles of m6A modifications in cancer drug resistance
Zaoqu Liu, Haijiao Zou, Qin Dang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 57
Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer
Chunmei Zhang, Ning Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56
Alkaline Phosphatase-Controllable and Red Light-Activated RNA Modification Approach for Precise Tumor Suppression
Jing Fang, Yali Feng, Yuqi Zhang, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 50, pp. 23061-23072
Closed Access | Times Cited: 40
m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation
Ke Wang, Gang Wang, Gang Li, et al.
APOPTOSIS (2023) Vol. 28, Iss. 3-4, pp. 627-638
Closed Access | Times Cited: 38
The pathogenesis and potential therapeutic targets in sepsis
Wendan Zhang, Honghong Jiang, Gaosong Wu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 33
PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma
Fei Song, Chenggui Wang, Jiazhen Mao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28
Autophagy activation is required for N6-methyladenosine modification to regulate ferroptosis in hepatocellular carcinoma
Yujia Li, Mei Guo, Yangling Qiu, et al.
Redox Biology (2023) Vol. 69, pp. 102971-102971
Open Access | Times Cited: 28
Inhibition of IGF2BP1 attenuates renal injury and inflammation by alleviating m6A modifications and E2F1/MIF pathway
Yan Mao, Feng Jiang, Xue-Jiao Xu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 2, pp. 593-609
Open Access | Times Cited: 27
Advances in research on immunocyte iron metabolism, ferroptosis, and their regulatory roles in autoimmune and autoinflammatory diseases
Liuting Zeng, Kailin Yang, Ganpeng Yu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 9
Taxifolin regulates SLC31A1-mediated cuproptosis and tumor progression in hepatocellular carcinoma
Jike Li, Yuelian Wang, Lei Bao, et al.
Human Cell (2025) Vol. 38, Iss. 2
Closed Access | Times Cited: 1
FTO Suppresses Proliferation and Induces Apoptosis of T98G Glioblastoma Cells via N6-methyladenosine Modification of GSTO1
Jinjiang Dong, J.P. Mao, Weihua Wu, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access | Times Cited: 1
The Emerging Role of m6A and Programmed Cell Death in Cardiovascular Diseases
Haixia Wang, Juanjuan Han, Hui Kong, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 247-247
Open Access | Times Cited: 1
N6-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m6A/PD-L1 manner
Yibing Wang, Peng Jin, Xia Wang
APOPTOSIS (2023) Vol. 29, Iss. 1-2, pp. 142-153
Closed Access | Times Cited: 22
Roles and implications of mRNA N6‐methyladenosine in cancer
Lingxing Zeng, Xudong Huang, Jialiang Zhang, et al.
Cancer Communications (2023) Vol. 43, Iss. 7, pp. 729-748
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top